DES MOINES, Iowa–(BUSINESS WIRE)–BioSpace, the leader in life sciences news and careers, today announced their NextGen Bio “Class of 2020,” a list of 21 up-and-coming life sciences companies in the United States.
The list represents some of the most promising new companies across the biopharma sector that are already making an impact in the industry and will have an even bigger impact in the future.
Cerevel Therapeutics topped the list, with Anthos Therapeutics, Century Therapeutics, Cyclerion Therapeutics and Mirium Pharmaceuticals rounding out the Top 5.
To come up with the NextGen Bio “Class of 2020,” BioSpace analyzed biopharma companies that launched* no earlier than mid-2018 and awarded points to the companies based on four categories: finance, collaborations, pipeline and innovation.
“The NextGen Class of 2020 represents some of the most exciting and innovative companies in the life sciences industry today,” said Joshua Goodwin, CEO of BioSpace. “We are proud to be able to showcase such distinguished companies and continue our mission of ‘championing the life sciences industry’.”
This is the sixth year that BioSpace has compiled a NextGen Bio “Class of …” list. Some companies that have previously been featured on BioSpace’s NextGen Bio list that have made a name for themselves in the industry include Denali Therapeutics, MyoKardia, BlueRock Therapeutics and SpringWorks Therapeutics among many others.
You can view the complete breakdown of the NextGen Bio “Class of 2020” here.
NextGen Bio “Class of 2020”
Cerevel Therapeutics, Anthos Therapeutics, Century Therapeutics, Cyclerion Therapeutics, Mirium Pharmaceuticals, Passage Bio, QPex Biopharma, Thrive Earlier Detection, Maze Therapeutics, Ribbon Therapeutics, HiberCell, Twentyeight-Seven Therapeutics, Verve Therapeutics, Kronos Bio, Motif FoodWorks, Talaris Therapeutics, Frontier Medicines, Tiburio Therapeutics, CuraSen, Gotham Therapeutics, Entrada Therapeutics.
Since 1985, BioSpace has provided essential insights, opportunities and tools to connect innovative life sciences organizations and talented professionals who advance health and quality of life across the globe. BioSpace continues to be the leading source for news and careers for life sciences professionals in the United States.
* Launch date was primarily chosen as the date of a Series A financing. This can vary dramatically from the date the company was founded, which is typically the date incorporation papers were filed. For purposes of an algorithm and simplification, with few exceptions during the sorting process, launch date was based on financing.
Jamie Jones, 515-350-7490